Trends in safety and cost of deep brain stimulation for treatment of movement disorders in the United States: 2002–2014

References

• Heath RG, Monroe RR, Mickle WA. Stimulation of the amygdaloid nucleus in a schizophrenic patient. AJP 1955;111:862–3.
   Google Scholar
• Hosobuchi Y. Chronic brain stimulation for the treatment of intractable pain. Res Clin Stud Headache 1978;5:122–6.
   PubMedGoogle Scholar
• Richardson DE. Thalamic stimulation in the control of pain. South Med J 1980;73:283–5.
   PubMed Web of Science ®Google Scholar
• Richardson DE, Akil H. Pain reduction by electrical brain stimulation in man. J Neurosurg 1977;47:184–94.
   PubMed Web of Science ®Google Scholar
• Brice J, McLellan L. Suppression of intention tremor by contingent deep-brain stimulation. Lancet 1980;315:1221–2.
   Google Scholar
• Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403–6.
   PubMed Web of Science ®Google Scholar
• Tierney TS, Sankar T, Lozano AM. Deep brain stimulation emerging indications. Prog Brain Res 2011;194:83–95.
   PubMed Web of Science ®Google Scholar
• Dowling J. Deep brain stimulation: current and emerging indications. Mo Med 2008;105:424–8.
   PubMedGoogle Scholar
• Gardner J. A history of deep brain stimulation: technological innovation and the role of clinical assessment tools. Soc Stud Sci 2013;43:707–28.
   Web of Science ®Google Scholar
• Deuschl G, Schade-Brittinger C, Krack P, German Parkinson Study Group, Neurostimulation Section, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006;355:896–908.
   PubMed Web of Science ®Google Scholar
• Schuepbach WMM, Rau J, Knudsen K, EARLYSTIM Study Group, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med 2013;368:610–22.
   PubMed Web of Science ®Google Scholar
• Weaver FM, Follett K, Stern M, CSP 468 Study Group, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. J Am Med Assoc 2009;301:63–73.
   PubMed Web of Science ®Google Scholar
• Hyam JA, Pereira EAC, McCulloch P, et al. Implementing novel trial methods to evaluate surgery for essential tremor. Br J Neurosurg 2015;29:334–9.
   PubMed Web of Science ®Google Scholar
• Rehncrona S, Johnels B, Widner H, Törnqvist A-L, Hariz M, Sydow O. Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments. Mov Disord 2003;18:163–70.
   PubMed Web of Science ®Google Scholar
• Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000;342:461–8.
   PubMed Web of Science ®Google Scholar
• Kupsch A, Benecke R, Müller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978–90.
   PubMed Web of Science ®Google Scholar
• Volkmann J, Mueller J, Deuschl G, DBS study group for dystonia, et al. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol 2014;13:875–84.
   PubMed Web of Science ®Google Scholar
• Kiss ZHT, Doig-Beyaert K, Eliasziw M, Tsui J, Haffenden A, Suchowersky O. The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain 2007;130:2879–86.
   PubMed Web of Science ®Google Scholar
• Vidailhet M, Vercueil L, Houeto J-L, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 2005;352:459–67.
   PubMed Web of Science ®Google Scholar
• Kalakoti P, Ahmed O, Bollam P, Missios S, Wilden J, Nanda A. Predictors of unfavorable outcomes following deep brain stimulation for movement disorders and the effect of hospital case volume on outcomes: an analysis of 33, 642 patients across 234 US hospitals using the National (Nationwide) Inpatient Sample from 2002 to 2011. FOC 2015;38:E4.
   Google Scholar
• Youngerman BE, Chan AK, Mikell CB, McKhann GM, Sheth SA. A decade of emerging indications: deep brain stimulation in the United States. JNS 2016;125:461–71.
   Google Scholar
• Rolston JD, Englot DJ, Starr PA, Larson PS. An unexpectedly high rate of revisions and removals in deep brain stimulation surgery: analysis of multiple databases. Parkinsonism Relat Disord 2016;33:72–7.
   PubMed Web of Science ®Google Scholar
• Chan AK, McGovern RA, Brown LT, et al. Disparities in access to deep brain stimulation surgery for Parkinson disease: interaction between African American race and Medicaid use. JAMA Neurol 2014;71:291–9.
   PubMed Web of Science ®Google Scholar
• Eskandar EN, Flaherty A, Cosgrove GR, Shinobu LA, Barker FG, 2nd. Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample. J Neurosurg 2003;99:863–71.
   PubMed Web of Science ®Google Scholar
• Lad SP, Kalanithi PS, Patil CG, et al. Socioeconomic trends in Deep Brain Stimulation (DBS) surgery. Neuromodul: Technol Neural Interface 2010;13:182–6.
   PubMed Web of Science ®Google Scholar
• Sharma M, Ambekar S, Guthikonda B, Wilden J, Nanda A. Regional trends and the impact of various patient and hospital factors on outcomes and costs of hospitalization between academic and nonacademic centers after deep brain stimulation surgery for Parkinson’s disease: a United States Nationwide Inpatient Sample analysis from 2006 to 2010. FOC 2013;35:E2.
   Google Scholar
• Arora V, Moriates C, Shah N. The challenge of understanding health care costs and charges. AMA J Ethics 2015;17:1046–52.
   PubMedGoogle Scholar
• Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96:102–9.
   PubMed Web of Science ®Google Scholar
• Averill RF, Goldfield N, Gregg LW, Shafir BV. The clinical development of an ambulatory classification system. J Ambulatory Care Manage 1997;20:49–56.
   PubMedGoogle Scholar
• HCUP-US Cost-to-Charge Ratio Files [online], 2018. Available from: www.hcup-us.ahrq.gov/db/state/costtocharge.jsp [last accessed 22 Mar 2018].
   Google Scholar
• Liu CY, Zygourakis CC, Yoon S, et al. Trends in utilization and cost of cervical spine surgery using the national inpatient sample database, 2001 to 2013. Spine 2017;42:E906–13.
   PubMed Web of Science ®Google Scholar
• Smith MW, Friedman B, Karaca Z, Wong HS. Predicting inpatient hospital payments in the United States: a retrospective analysis. BMC Health Serv Res 2015;15:372.
   PubMed Web of Science ®Google Scholar
• Zygourakis CC, Liu CY, Wakam G, et al. Geographic and hospital variation in cost of Lumbar Laminectomy and Lumbar Fusion for degenerative conditions. Neurosurgery 2017;81:331–40.
   PubMed Web of Science ®Google Scholar
• Twelves D, Perkins KSM, Counsell C. Systematic review of incidence studies of Parkinson’s disease. Mov Disord 2003;18:19–31.
   PubMed Web of Science ®Google Scholar
• Okun MS, Foote KD. Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev Neurother 2010;10:1847–57.
   PubMed Web of Science ®Google Scholar
• Okun MS, Tagliati M, Pourfar M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005;62:1250–5.
   PubMed Web of Science ®Google Scholar
• Sanghera MK, Desaloms MJ, Stewart MR. High-frequency stimulation of the subthalamic nucleus for the treatment of Parkinson's disease-a team perspective . J Neurosci Nurs 2004;36:301–11.
   PubMedGoogle Scholar
• Peto V, Jenkinson C, Fitzpatrick R. Determining minimally important differences for the PDQ-39 Parkinson’s disease questionnaire. Age Ageing 2001;30:299–302.
   PubMed Web of Science ®Google Scholar
• Beric A, Kelly PJ, Rezai A, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg 2001;77:73–8.
   PubMed Web of Science ®Google Scholar
• Lyons KE, Wilkinson SB, Overman J, Pahwa R. Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology 2004;63:612–6.
   PubMed Web of Science ®Google Scholar
• Voges J, Waerzeggers Y, Maarouf M, et al. Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery–experiences from a single centre. J Neurol Neurosurg Psychiatry 2006;77:868–72.
   PubMed Web of Science ®Google Scholar
• Larson PS. Deep brain stimulation for movement disorders. Neurotherapeutics: J Am Soc Exp NeuroTherapeutics 2014;11:465–74.
   PubMed Web of Science ®Google Scholar
• Verla T, Marky A, Farber H, et al. Impact of advancing age on post-operative complications of deep brain stimulation surgery for essential tremor. J Clin Neurosci: Off J Neurosurg Soc Australasia 2015;22:872–6.
   PubMed Web of Science ®Google Scholar
• Hu W, Stead M. Deep brain stimulation for dystonia. Transl Neurodegener 2014;3:2.
   PubMedGoogle Scholar
• Sun B, Li D, Zhan S, Zhang J. 3.1.4 Subthalamic nucleus stimulation for primary dystonia and tardive dyskinesia: long-term follow up results. Parkinsonism Relat Disord 2012;18:S161–S2.
   PubMedGoogle Scholar
• Qaseem A, Snow V, Fitterman N, et al., for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 2006;144:575–80.
   PubMed Web of Science ®Google Scholar
• Fernandez MM, Hogue S, Preblick R, Kwong WJ. Review of the cost of venous thromboembolism. Clin-Econ Outcomes Res: CEOR 2015;7:451–62.
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. JMCP 2007;13:475–86.
   PubMed Web of Science ®Google Scholar
• Bauman JA, Church E, Halpern CH, et al. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis. Neurosurgery 2009;65:276–80. discussion 280.
   PubMed Web of Science ®Google Scholar
• Umemura A, Jaggi JL, Hurtig HI, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg 2003;98:779–84.
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Cost-to-Charge Ratio Files: User Guide for National Inpatient Sample (NIS) CCRs [online]; 2018. Healthcare Cost and Utilization Project. Available from: https://www.hcup-us.ahrq.gov/db/state/CCR_NIS_UserGuide_2001-2016.pdf [last accessed Oct 2018].
   Google Scholar
• Barrett M, Yan G, Abbott RD, Willis AW. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology 2014;83:1684–5.
   PubMed Web of Science ®Google Scholar
• Bour LJ, Contarino MF, Foncke EMJ, et al. Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi. Acta Neurochir 2010;152:2069–77.
   PubMed Web of Science ®Google Scholar
• Diamond A, Shahed J, Azher S, Dat-Vuong K, Jankovic J. Globus pallidus deep brain stimulation in dystonia. Mov Disord 2006;21:692–5.
   PubMed Web of Science ®Google Scholar
• Dams J, Siebert U, Bornschein B, et al. Cost-effectiveness of deep brain stimulation in patients with Parkinson’s disease. Mov Disord 2013;28:763–71.
   PubMed Web of Science ®Google Scholar
• Eggington S, Valldeoriola F, Ray Chaudhuri K, Ashkan K, Annoni E, Deuschl G. The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease. J Neurol 2014;261:106–16.
   PubMed Web of Science ®Google Scholar
• Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness–the curious resilience of the $50,000-per-QALY threshold. N Engl J Med 2014;371:796–7.
   PubMed Web of Science ®Google Scholar